Delaying treatment after destroying lung spots from colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests if it's safe to wait before starting full-body therapy after treating a small number of lung tumors (5 or fewer) in people whose colorectal cancer had been gone for at least 6 months. You would first get local treatments like surgery or radiation to destroy the lung spots, then delay additional cancer drugs to see how you do.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colorectal cancer that was treated and showed no signs of disease for at least 6 months.
- You now have 5 or fewer lung tumors that can be destroyed with local treatments like surgery, heat, or radiation.
- You have not had radiation to the lungs before.
- You have not received more than one type of systemic cancer therapy (chemotherapy or targeted pills).
- Your overall health allows you to walk around and take care of yourself (ECOG score 0–2).
- Your organs (kidneys, liver, lungs, heart) work well enough for local treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether treating all liver tumors with surgery, ablation, or radiation is better than continuing standard chemotherapy for people with colorectal cancer that has spread only to the liver. It's for those whose liver tumors have been controlled by initial chemotherapy and are considered removable.
This trial tests a procedure that places tiny radioactive seeds directly into tumors that have started growing again in patients with lung or colorectal cancer that has spread. It combines this with standard drug therapy to see if it can better control the disease.
This Phase 1 trial tests a targeted treatment delivered to the lungs for colorectal cancer that has spread to the lungs. It aims to see if the approach is safe and can reach lung tumors, especially when there are multiple lung lesions.
This Phase 2 study tests the best way to choose and then follow treatment when colorectal cancer has spread only to a small number of spots. You may be eligible if your doctors can remove or precisely treat the spots and there’s no sign of additional spread on scans.
This trial studies how targeted radiation (SBRT) affects cancer biology and immune cells in people with colon cancer that has spread only to a small number of lung nodules. Your tumor tissue will be analyzed to see what changes after treatment.
This trial tests a combination of precise radiation to liver or lung tumors plus immunotherapy for people with advanced colorectal cancer that cannot be surgically removed. It aims to see if this approach can help control the cancer.
Hear when a new Colorectal Neoplasms Malignant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.